<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-08-22">August 22, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Julia</forename><surname>Siede</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Experimental Immunology and Osteoarthritis Research</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Rheumatism Research Center (DRFZ)</orgName>
								<orgName type="laboratory">Pitzer Laboratory of Osteoarthritis Research</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anja</forename><surname>Fröhlich</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Experimental Immunology and Osteoarthritis Research</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Rheumatism Research Center (DRFZ)</orgName>
								<orgName type="laboratory">Pitzer Laboratory of Osteoarthritis Research</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Angeliki</forename><surname>Datsi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Experimental Immunology and Osteoarthritis Research</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Rheumatism Research Center (DRFZ)</orgName>
								<orgName type="laboratory">Pitzer Laboratory of Osteoarthritis Research</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ahmed</forename><forename type="middle">N</forename><surname>Hegazy</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Translational Gastroenterology Unit</orgName>
								<orgName type="department" key="dep2">Department of Clinical Medicine</orgName>
								<orgName type="department" key="dep3">Experimental Medicine Division</orgName>
								<orgName type="institution">John Radcliffe Hospital</orgName>
								<address>
									<settlement>Nuffield</settlement>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<settlement>Oxford</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences</orgName>
								<orgName type="institution">The Kennedy Institute of Rheumatology</orgName>
								<address>
									<settlement>Nuffield</settlement>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<settlement>Headington, Oxford</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Domonkos</forename><forename type="middle">V</forename><surname>Varga</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Experimental Immunology and Osteoarthritis Research</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Rheumatism Research Center (DRFZ)</orgName>
								<orgName type="laboratory">Pitzer Laboratory of Osteoarthritis Research</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Vivien</forename><surname>Holecska</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Experimental Immunology and Osteoarthritis Research</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Rheumatism Research Center (DRFZ)</orgName>
								<orgName type="laboratory">Pitzer Laboratory of Osteoarthritis Research</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hirohisa</forename><surname>Saito</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Allergy and Immunology</orgName>
								<orgName type="institution">National Research Institute for Child Health and Development</orgName>
								<address>
									<settlement>Tokyo</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Susumu</forename><surname>Nakae</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Center for Experimental Medicine and Systems Biology</orgName>
								<orgName type="department" key="dep2">The Institute of Medical Science</orgName>
								<orgName type="laboratory">Laboratory of Systems Biology</orgName>
								<orgName type="institution">The University of Tokyo</orgName>
								<address>
									<settlement>Tokyo</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Precursory Research for Embryonic Science and Technology</orgName>
								<orgName type="institution">Japan Science and Technology Agency</orgName>
								<address>
									<settlement>Saitama</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Max</forename><surname>Löhning</surname></persName>
							<email>loehning@drfz.de</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Experimental Immunology and Osteoarthritis Research</orgName>
								<orgName type="department" key="dep2">Department of Rheumatology and Clinical Immunology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">German Rheumatism Research Center (DRFZ)</orgName>
								<orgName type="laboratory">Pitzer Laboratory of Osteoarthritis Research</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">Leibniz Institute</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="institution">University of Lisbon</orgName>
								<address>
									<country key="PT">PORTUGAL</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-08-22">August 22, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">97425C557AF07F7EFC8629634C38F2F7</idno>
					<idno type="DOI">10.1371/journal.pone.0161507</idno>
					<note type="submission">Received: May 11, 2016 Accepted: August 5, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:30+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>coLP, colonic lamina propria</term>
					<term>LN, lymph nodes</term>
					<term>NLT, non-lymphoid tissues</term>
					<term>pLN, peripheral lymph nodes</term>
					<term>SI, small intestine</term>
					<term>siLP, small intestinal lamina propria</term>
					<term>Spl, spleen</term>
					<term>Treg, regulatory T cell</term>
					<term>Tresp, responder T cells</term>
					<term>VAT, visceral adipose tissue</term>
					<term>FACS, fluorescence activated cell sorting</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Immunomodulatory Foxp3 + regulatory T cells (Tregs) form a heterogeneous population consisting of subsets with different activation states, migratory properties and suppressive functions.</s><s>Recently, expression of the IL-33 receptor ST2 was shown on Tregs in inflammatory settings.</s><s>Here we report that ST2 expression identifies highly activated Tregs in mice even under homeostatic conditions.</s><s>ST2 + Tregs preferentially accumulate at non-lymphoid sites, likely mediated by their high expression of several chemokine receptors facilitating tissue homing.</s><s>ST2 + Tregs exhibit a Th2-biased character, expressing GATA-3 and producing the Th2 cytokines IL-5 and IL-13 -especially in response to IL-33.</s><s>Yet, IL-33 is dispensable for the generation and maintenance of these cells in vivo.</s><s>Furthermore, ST2 + Tregs are superior to ST2 − Tregs in suppressing CD4 + T cell proliferation in vitro independent of IL-33.</s><s>This higher suppressive capacity is partially mediated by enhanced production and activation of the anti-inflammatory cytokines IL-10 and TGFβ.</s><s>Thus, ST2 expression identifies a highly activated, strongly suppressive Treg subset preferentially located in non-lymphoid tissues.</s><s>Here ST2 + Tregs may be well positioned to immediately react to IL-33 alarm signals.</s><s>Their specific properties may render ST2 + Tregs useful targets for immunomodulatory therapies.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Regulatory Foxp3 + CD4 + T cells (Tregs) are key controllers of immune homeostasis.</s><s>They maintain immune tolerance, thus preventing autoimmunity or excessive inflammation <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>They are present in almost all tissues, even under homeostatic conditions, and regulate a variety of innate and adaptive immune cells <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref>.</s><s>Various mechanisms mediating Treg functions have been described.</s><s>These include direct suppression or cytolysis of target cells, repression of APC maturation and function as well as secretion and activation of anti-inflammatory cytokines such as IL-10 and TGFβ <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>Consequently, Tregs form a heterogeneous population displaying diverse migratory properties and immunomodulatory effects.</s></p><p><s>A minor fraction of Tregs in the circulation and lymphatic organs exhibits an activated effector/memory T cell phenotype similar to conventional T cells, thus termed effector Tregs.</s><s>These Tregs are assumed to have encountered antigen more recently and preferentially reside in non-lymphoid tissues (NLT) <ref type="bibr" target="#b6">[7]</ref>.</s><s>Several surface markers distinguishing effector Tregs have been identified so far, including αE integrin (CD103) which marks a subset of highly suppressive, rapidly activated Tregs that preferentially resides in NLT <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>.</s><s>A similar phenotype is observed in KLRG1-expressing Tregs that accumulate in the lung in a model of airway inflammation, accompanied by increased levels of CD44, CD69, CD25, CTLA-4 and a downregulation of CD62L <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>.</s><s>In general, effector Tregs display classical T cell activation markers, like CD44 hi and CD62L lo , along with molecules involved in Treg maintenance and function, such as Foxp3, CTLA-4, KLRG1, CD103 and ICOS and are thought to be highly suppressive.</s></p><p><s>A growing body of evidence suggests that the acquisition of an effector-like phenotype does not mark the end point of Treg differentiation.</s><s>Instead, further diversification comparable to conventional T cells may occur <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref>.</s><s>Notably, the Th2 lineage-specifying transcription factor GATA-3 can be upregulated in Tregs upon encounter of antigen and IL-2 <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b17">18]</ref>.</s><s>In Th2 cells, GATA-3 induces transcription of the Il1rl1 gene, encoding ST2, the receptor for the alarmin IL-33 <ref type="bibr" target="#b18">[19]</ref>.</s><s>Recently, it was shown that ST2 is also expressed on a subset of Tregs in a GATA-3-dependent manner <ref type="bibr" target="#b19">[20]</ref>.</s><s>Additional studies revealed that systemic administration of IL-33 increased the number of total and ST2 + Tregs resulting in a delay of graft-versus-host disease and amelioration of colitis <ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref>.</s><s>Moreover, in a setting of acute inflammation, IL-33 signals are essential for the accumulation of ST2 + Tregs in mucosal tissue and the stability of the Treg phenotype <ref type="bibr" target="#b19">[20]</ref>.</s><s>Yet, ST2 + Tregs are present in several organs even under homeostatic conditions <ref type="bibr" target="#b23">[24]</ref>, but their phenotype and suppressive capacity at steady-state remain ill defined.</s></p><p><s>Here we report that ST2 + Tregs are highly activated effector Tregs that preferentially accumulate in NLT.</s><s>They exhibit a Th2-like phenotype with elevated expression of GATA-3 and production of the Th2 cytokines IL-5 and IL-13, which can be further augmented by IL-33 signals.</s><s>In line with their effector-like phenotype, ST2 + Tregs suppress naïve CD4 + T cell proliferation more effectively than their ST2 − counterparts-independent of IL-33.</s><s>Both IL-10 and increased TGFβ production and activation contribute to the suppressive mechanism employed by ST2 + Tregs.</s><s>Finally, we demonstrate that IL-33 is dispensable for the generation, maintenance and tissue accumulation of ST2 + Tregs under homeostatic conditions.</s><s>Taken together, ST2 + Tregs form a highly suppressive subset located in prime position to react to inflammatory processes involving the release of IL-33.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Material and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mice</head><p><s>Il33 -/- <ref type="bibr" target="#b24">[25]</ref>, Il1rl1 -/- <ref type="bibr" target="#b25">[26]</ref> and WT mice were bred on C57BL/6 background under SPF conditions at the Charité animal facility, Berlin.</s><s>B6.Foxp3 hCD2 reporter mice <ref type="bibr" target="#b26">[27]</ref> were crossed to Il10 gfp reporter <ref type="bibr" target="#b27">[28]</ref> under SPF conditions at animal facilities at the University of Oxford, UK.</s></p><p><s>Experiments were performed at the Charité and DRFZ, Berlin, in accordance with national law for animal protection with permission from the Landesamt für Gesundheit und Soziales (Lageso); permission number T0058/08.</s><s>Experiments at the University of Oxford were approved by the Clinical medicine AWERB committee at the University of Oxford.</s><s>Animals were euthanized by cervical dislocation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>T cell isolation for ex vivo characterization</head><p><s>Blood was drawn from animals before they were euthanized and perfused with PBS.</s><s>Circulating lymphocytes were isolated by high density centrifugation using Histopaque (Sigma-Aldrich).</s><s>Lungs were chopped, treated with 0.1U/ml Collagenase D (Roche), homogenized and applied to a Histopaque gradient.</s><s>Spleen and LN were homogenized and splenic erythrocytes were lysed.</s><s>Payer's patches were removed from the small intestine (SI).</s><s>Colon and SI were cut and incubated in RPMI with 1mM DTT, 5mM EDTA, 5% FCS, homogenized and treated with 0.1U/ml Collagenase D. Single cell suspensions were applied to a 40/70% Percoll gradient.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow cytometric analysis and sorting</head><p><s>Samples were stained with antibodies against CD4 (GK1.5),</s><s>CD25 (PC61), KLRG1 (2F1), CD103 (2E7), CD62L (MEL-14), CD44 (IM7), LPAM-1/α4β7 (DATK32), CD183/CXCR3 (CXCR3-173), CD194/CCR4 (2G12), CD196/CCR6 (29-2L17), CD197/CCR7 (4B12), CD199/ CCR9 (CW-1.2),</s><s>anti-hCD2 (RPA-2.10)</s><s>and ST2 (DJ8) in PBS/0.2%</s><s>BSA/2mM EDTA.</s><s>ST2 staining was amplified using FASER-Kit-PE or FASER-Kit-APC (Miltenyi Biotec).</s><s>CTLA-4 (UC10-4B9) staining was performed after fixation.</s><s>T-bet (4B10), GATA-3 (TWAJ), and Foxp3 (FJK-16S) were stained using the Foxp3 staining buffer set (eBioscience).</s><s>GATA-3 index depicts the MFI ratio of GATA-3 and its respective isotype (eB149/10H5) staining.</s><s>Samples were acquired on FACSCanto II (BD Biosciences) and analyzed using FlowJo (FlowJo) or FCAP array software (BD).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>T cell cultures and suppression assays</head><p><s>CD4 + T cells from spleen and LN were enriched by magnetic cell separation (MACS, Miltenyi Biotec).</s><s>CD4 + CD25 + ST2 + or CD4 + CD25 + ST2 − T cells (Tregs) and CD4 + CD62L + CD44 lo (Tresp) were purified by FACS.</s><s>For Treg stimulation, 96-well flat-bottom plates were coated with 3μg/ml anti-CD3 (145-2C11) and 6μg/ml anti-CD28 (37.51) antibodies.</s><s>2x10 4 to 1x10 5  Tregs were resuspended in 140-200μl of RPMI/10% FCS supplemented with 40ng/ml IL-2 with or without 30ng/ml IL-33.</s><s>After 60-70h, supernatants were collected and cytokines were quantified by cytometric bead array (BD Pharmingen).</s></p><p><s>For suppression assays, Tresp were labeled with CellTrace Violet or CFSE (Invitrogen).</s><s>APCs were isolated from splenocytes by MACS using biotinylated anti-CD19 (1D3), anti-CD11b (M1/70) and anti-CD11c (HL3) antibodies and anti-biotin microbeads (Miltenyi Biotec).</s><s>IL-10 signaling was blocked by pre-incubation of Tresp with 50μg/ml anti-CD210/IL-10R (1B1.3a).</s><s>TGFβ signaling was blocked using 10μM TGFβRI inhibitor in DMSO (SB431542, Merck Millipore) directly in culture.</s><s>Control cells were treated with DMSO alone.</s><s>The Treg: Tresp ratio was varied as indicated; twice as much APCs and 5μg/ml anti-CD3 antibody were added.</s><s>Proliferation of Tresp was analyzed on day 4 by flow cytometry.</s><s>The division index indicates the average number of divisions that a cell in the starting population has undergone.</s><s>The relative division index was normalized to the corresponding untreated population.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>mRNA isolation and quantification</head><p><s>RNA was isolated using the miRNeasy mini kit (Qiagen).</s><s>Complementary DNA was synthesized using the Taqman Reverse Transcription Reagents (Life Technologies).</s><s>Quantitative RT-PCR reactions were performed in duplicates using SYBR Select Master Mix (Life Technologies), respective primers (S1 Table <ref type="table">)</ref> on a QuantStudio 7 real-time PCR system (Life Technologies).</s><s>Data was normalized to Hprt endogenous control.</s></p><p><s>All reagents and kits were used at manufacturer's recommendation, if not stated otherwise.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Two groups were compared with two-tailed unpaired Student's t test (GraphPad Prism 5.02); Ã p 0.05; ÃÃ p 0.01; ÃÃÃ p 0.001; non-significant (ns) p &gt; 0.05.</s><s>First, CXCR3, involved in Treg recruitment to inflammatory sites <ref type="bibr" target="#b29">[30]</ref>, was significantly higher expressed on ST2 + than ST2 − Tregs in all organs analyzed but the lung, suggesting an increased potential of ST2 + Tregs to home to those organs.</s><s>However, expression was highest in the lung hinting towards a general requirement for lung-homing Tregs to express CXCR3.</s><s>Second, CCR9 and α4β7 integrin are strong promoters of lymphocytic migration to the intestinal lamina propria <ref type="bibr" target="#b30">[31]</ref>.</s><s>Their expression was significantly higher on ST2 + than ST2 − Tregs found in the gut.</s><s>Third, CCR4 has been implicated in enhanced migration of Tregs to the skin and lung to control local inflammation <ref type="bibr" target="#b9">[10]</ref>.</s><s>We found significantly higher CCR4 expression on ST2 + Tregs, suggesting preferential migration to these sites.</s><s>Last, CCR7, a homing marker for secondary lymphoid organs <ref type="bibr" target="#b31">[32,</ref><ref type="bibr" target="#b32">33]</ref>, was significantly lower expressed on ST2 + than ST2 − Tregs.</s><s>Taken together, these results indicate that ST2 + Tregs accumulate in NLT, presumably facilitated by their distinct chemokine receptor and integrin expression pattern.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ST2 + Tregs arise independently of IL-33 signals</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ST2 + Tregs display a highly activated phenotype</head><p><s>Next, we analyzed the expression of molecules associated with Treg function and activation on ST2 + and ST2 − Treg subsets.</s><s>Both KLRG1 and CD103 have been described to be expressed on highly suppressive Tregs with the capacity to home to inflamed tissues <ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>.</s><s>Around 70% of splenic ST2 + Tregs expressed either one or both of these markers compared to only about 10% in the ST2 − Treg compartment.</s><s>A similar distribution was observed in the pLN and lung (Fig <ref type="figure" target="#fig_3">2C</ref>).</s><s>These data suggest that the ST2 + Treg subset is largely comprised of highly differentiated and suppressive Tregs.</s><s>To provide further evidence for the activated phenotype of ST2 + Tregs, two classical activation-associated surface molecules were assessed.</s><s>While CD44 expression on Tregs is correlated with increased suppressive capacity <ref type="bibr" target="#b33">[34]</ref>, the role of CD62L in Treg functionality is controversially discussed <ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref>.</s><s>We found that ST2 + Tregs expressed high levels of CD44 and low levels of CD62L.</s><s>Additionally, CTLA-4 is crucial for the suppressive function of Tregs <ref type="bibr" target="#b37">[38]</ref>.</s><s>Indeed, the frequency of CTLA- At the mRNA level we could confirm a higher expression of Il1rl1 (ST2) and Foxp3 in ST2 + Tregs (Fig <ref type="figure" target="#fig_3">2F</ref>).</s><s>Furthermore, the expression of two molecules associated with a highly activated and suppressive Treg phenotype, Icos and Prdm1 (Blimp1) <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b39">40]</ref>, was significantly increased in the ST2 + compared to the ST2 − Treg subset.</s><s>Next, we assessed the production of the antiinflammatory cytokine IL-10, whose expression in Tregs under homeostatic conditions is dependent on Blimp1 <ref type="bibr" target="#b39">[40]</ref> and has been shown to confer Treg function <ref type="bibr" target="#b40">[41]</ref>.</s><s>In all organs, ST2 + Tregs displayed an increased capability to produce IL-10 when compared with ST2 − Tregs, with greatest differences detectable in the lung (Fig <ref type="figure" target="#fig_3">2G</ref>).</s><s>Overall, these data suggest that the ST2 + Treg subset combines various characteristics of highly activated, differentiated and suppressive Tregs.</s><s>proliferation at all ratios tested, ST2 + Tregs were considerably more suppressive (Fig 3A <ref type="figure" target="#fig_4">and  3B</ref>).</s><s>However, the addition of IL-33 had no beneficial effect on their suppressive capacity, but resulted in a selective increase of ST2 expression on ST2 + Tregs (Fig 3C <ref type="figure">)</ref>.</s></p><p><s>Taken together, these results demonstrate that ST2 + Tregs strongly suppress CD4 + responder T cell proliferation.</s><s>This property appears to be independent of their ability to receive and process IL-33 signals through the ST2 receptor.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ST2 + Tregs suppress responder T cells via IL-10 and TGFβ release and activation</head><p><s>Both IL-10 and TGFβ are thought to at least partially mediate the suppressive function of Tregs <ref type="bibr" target="#b41">[42]</ref>.</s><s>Since ST2 + Tregs produce significantly higher amounts of these cytokines than their ST2 − counterparts, we addressed if these cytokines contribute to the increased suppressive capacity of ST2 + Tregs.</s><s>Therefore, we blocked IL-10 or TGFβ signaling during in vitro suppression assays (Fig <ref type="figure" target="#fig_6">4E</ref>).</s><s>The blockade of IL-10 signaling by antibodies targeting the IL-10 receptor increased the proliferation of Tresp to a similar extent in the presence of ST2 + and ST2 − Tregs, hinting at similar contribution of IL-10 to the suppressive mechanisms of both Treg subsets despite differences in the secreted amount.</s><s>In contrast, the application of a TGFβ receptor I inhibitor <ref type="bibr" target="#b42">[43]</ref> resulted in enhanced proliferation of Tresp cultured in the presence of ST2 + Tregs, whereas Tresp alone or cultured with ST2 -Tregs were only marginally affected.</s><s>This finding suggests a major contribution of TGFβ signaling to the suppressive mechanism of ST2 + but not ST2 -Tregs.</s><s>In fact, not only the production of total TGFβ was higher in ST2 + Tregs but also the expression of integrin αvβ8 (Itgav and Itgb8) associated with the activation of latent TGFβ <ref type="bibr" target="#b43">[44]</ref> (Fig 4F <ref type="figure">)</ref>.</s><s>Taken together, these data demonstrate that ST2 + Tregs employ a mechanism based on IL-10 and increased TGFβ production and activation to at least partially mediate their highly suppressive function.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Recently, the expression of the IL-33 receptor ST2 was found on a subset of regulatory T cells <ref type="bibr">[20-22, 24, 45]</ref>.</s><s>However, their phenotype and tissue distribution under homeostatic conditions as well as the suppressive mechanism employed by these cells are still poorly understood.</s><s>Here we report that ST2 + Tregs display a Th2-biased effector Treg phenotype and strongly suppress naïve CD4 + T cell proliferation; an effect partially mediated by the anti-inflammatory cytokines IL-10 and TGFβ.</s></p><p><s>We observed that at steady-state, ST2 + Tregs preferentially accumulated at non-lymphoid tissues, such as the lung, the lamina propria of the small intestine and colon as well as the circulation.</s><s>These findings are in agreement with previous data obtained in inflammatory settings that show an accumulation of ST2 + Tregs in the colon <ref type="bibr" target="#b19">[20]</ref>, the lung and especially the visceral adipose tissue (VAT) <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b45">46]</ref>.</s><s>IL-33 is constitutively expressed in the nucleus of epithelial and endothelial cells and released upon necrotic cell death <ref type="bibr" target="#b46">[47,</ref><ref type="bibr" target="#b47">48]</ref>.</s><s>However, under homeostatic conditions IL-33 release is very limited.</s><s>Thus, our data demonstrate that signaling via the ST2 receptor is dispensable for the generation, maintenance and tissue accumulation of ST2 + Tregs.</s><s>Notably, VAT Tregs form an exception.</s><s>This specialized, self-contained Treg subset, which also expresses the transcription factor PPARγ associated with adipocyte differentiation <ref type="bibr" target="#b48">[49]</ref>, is highly dependent on the IL-33/ST2 axis for their stability and function in the VAT <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b45">46,</ref><ref type="bibr" target="#b49">50]</ref>.</s></p><p><s>Regarding ST2 + Treg tissue migration, we identified chemokine receptors and integrins associated with NLT homing to be particularly highly expressed in the ST2 + Treg compartment, including CXCR3, CCR4, CCR6, CCR9, αE (CD103) and α4β7 integrin.</s><s>Migration along the respective chemokine gradients could contribute to the positioning and retention of ST2 + Tregs at mucosal surfaces already under homeostatic conditions, leaving them in prime position to react to IL-33 danger signals.</s><s>Low-level release of IL-33 due to constant minor cell damage may contribute to the augmented ST2 expression per cell observed at barrier tissues.</s></p><p><s>We and others <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b23">24]</ref> demonstrated that ST2 + Tregs belong to a subset of highly activated effector Tregs based on their accumulation at NLT and expression of typical T cell activation markers and molecules involved in Treg maintenance and function.</s><s>Recently, a subset of effector Tregs expressing the B cell-associated transcription factor Blimp1 was characterized <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b39">40]</ref>.</s><s>The authors report that Blimp1 is essential for the production of IL-10 by effector Tregs.</s><s>Indeed, we found high expression of Prdm1 (Blimp1) in the ST2 + Treg compartment, paired with an increased IL-10 production capability in vitro and in vivo.</s><s>Moreover, transcriptome analysis of Blimp1 + and Blimp1 -Tregs revealed a strong enrichment for ST2 in the Blimp1 + Treg subset <ref type="bibr" target="#b23">[24]</ref>.</s><s>Overall, these findings suggest a considerable overlap between the ST2 + and Blimp1 + effector Treg populations.</s></p><p><s>The Th2 lineage-defining transcription factor GATA-3 is a known inducer of ST2 expression in Tregs <ref type="bibr" target="#b19">[20]</ref>.</s><s>In line with previous reports <ref type="bibr" target="#b45">[46]</ref>, we detected particularly high levels of GATA-3 in the ST2 + Treg compartment.</s><s>Furthermore, these cells also secreted increased amounts of Th2-associated cytokines IL-5 and IL-13.</s><s>In contrast to IL-4 which is produced neither by ST2 + nor ST2 -Tregs, GATA-3 has been reported to directly bind to the proximal promoters of IL-5 and IL-13 resulting in their expression <ref type="bibr" target="#b50">[51]</ref><ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref>.</s><s>Additionally the expression of these cytokines can be further augmented by IL-33.</s><s>However, we did not detect significant changes in GATA-3 expression upon IL-33 signals implying a mere supportive role of ST2 signaling on GATA-3 function.</s><s>In contrast, in vivo administration of IL-33 not only expands Tregs but also increases GATA-3 expression in the ST2 + Treg compartment <ref type="bibr" target="#b21">[22]</ref>, but such a setting is more complex and secondary effects may contribute to the GATA-3 upregulation.</s><s>Although IL-33 signals significantly expanded or promoted the survival of ST2 + Tregs in vitro, the increased amounts of the Th2 cytokines IL-5 and IL-13 released by these cells were not only a result of this expansion, but also of increased cytokine transcription.</s><s>First reports indicate that Th2 cytokine production by human Tregs results in an anti-inflammatory phenotype of alternatively activated macrophages <ref type="bibr" target="#b53">[54]</ref>.</s><s>However, more studies are necessary to determine the full functional consequences of Th2 cytokine secretion by Tregs.</s></p><p><s>In accordance with their effector-like phenotype <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b10">11]</ref>, ST2 + Tregs were superior in suppressing naïve CD4 + T cell proliferation compared to their ST2 − counterparts.</s><s>Yet, the comparison of ST2 + and ST2 − Tregs expanded in vivo by IL-33 injection has revealed only insignificant differences in suppressive capacity between the groups <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b21">22]</ref>.</s><s>Severe alterations in the hematopoietic compartment upon IL-33 administration <ref type="bibr" target="#b54">[55]</ref> including a potential upregulation of ST2 on expanding non-effector Tregs may be the underlying cause of this discrepancy.</s><s>In line with previous data <ref type="bibr" target="#b19">[20]</ref>, we observed a similar suppressive capacity of ST2-deficient and WT Tregs, either due to the low abundance of ST2 + effector Tregs within the WT Treg compartment or a similar effector Treg frequency in Il1rl1 -/mice.</s><s>Furthermore, the addition of IL-33 had no effect on the suppressive capacities of ST2 + and ST2 -Tregs, despite an expansion of ST2 + Tregs.</s><s>Such suppressive inertia to IL-33 signals might be due to Tregs exerting their most suppressive effects immediately after stimulation, whereas the cell number only gradually increases.</s><s>Thus, ST2 signaling seems dispensable for the high suppressive function of ST2 + Tregs derived from secondary lymphoid organs.</s><s>However, in NLT-derived ST2 + Tregs which express ST2 at a higher per cell amount, IL-33 signaling might be able to enhance their suppressive capacity.</s></p><p><s>Notably, IL-33 has recently been associated with Treg-mediated wound healing in a number of different tissues <ref type="bibr" target="#b55">[56,</ref><ref type="bibr" target="#b56">57]</ref>.</s><s>Injury-induced release of IL-33 from the parenchyma resulted in the release of tissue-protective epidermal growth factor ligand amphiregulin from ST2 + Tregs <ref type="bibr" target="#b55">[56]</ref>.</s><s>Thus, ST2 + Tregs might present dual functionality towards limiting local tissue inflammation: on the one hand by strongly suppressing pro-inflammatory T cell responses and on the other hand by directly triggering tissue repair processes in an IL-33-dependent manner.</s></p><p><s>A variety of mechanisms have been proposed to mediate Treg suppressive function: (1) direct target killing or suppression via IL-2 deprivation, granzyme B secretion and CD39/ 73-mediated ATP reduction; (2) repression of APC maturation and function via CTLA-4 and Lag3 signaling; and (3) secretion and activation of anti-inflammatory cytokines IL-10, TGFβ and IL-35 <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>Indeed, we detected high expression of CTLA-4, IL-10 and TGFβ in the ST2 + Treg subset, while others have already identified high levels of Lag3 and CD39 <ref type="bibr" target="#b21">[22]</ref>.</s><s>Furthermore, we provide evidence that both IL-10 and to a greater extend TGFβ contributed to the suppressive capacity of ST2 + Tregs.</s><s>High TGFβ and integrin αvβ8 expression was detected in ST2 + Tregs indicating an advantage of ST2 + Tregs to produce and activate latent TGFβ <ref type="bibr" target="#b43">[44]</ref>.</s><s>In agreement with the unresponsiveness of ST2 + Tregs to IL-33 concerning their suppressive capacity, IL-10 and TGFβ secretion also remained unaffected.</s><s>Additionally, absence of APCs from the suppression assay system did not alter the suppressive capacity of ST2 + Tregs (data not shown) suggesting that under these conditions, ST2 + Tregs directly suppress their target cells.</s></p><p><s>However, the role of IL-10 and TGFβ in suppressing Tresp proliferation in vitro remains controversially discussed, with some reports claiming a contribution of these cytokines to the suppressive mechanism of Tregs <ref type="bibr" target="#b57">[58,</ref><ref type="bibr" target="#b58">59]</ref> and others not <ref type="bibr" target="#b59">[60]</ref><ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b61">[62]</ref>.</s><s>Yet, the amount of IL-10 and TGFβ produced by the studied Treg populations might strongly influence the observed effect of these cytokines on suppression.</s><s>As already mentioned, ST2 + effector Tregs produce higher amounts of IL-10 and TGFβ compared with their ST2counterparts.</s><s>Thus, blockade of IL-10 and TGFβ signaling can exert a greater effect on ST2 + Treg-mediated suppression, which is readily detected in in vitro suppression assays.</s><s>However, the reduction in suppression upon IL-10R blockade was comparable between ST2 + and ST2 -Tregs, despite greater IL-10 production by ST2 + Tregs.</s><s>This observation might be explained by an incomplete IL-10R blockade or a generally minor contribution of IL-10 to Treg-mediated suppression in vitro.</s></p><p><s>In summary, we demonstrate that ST2 expression identifies a highly activated, strongly suppressive Treg subset located in non-lymphoid tissues.</s><s>The phenotype and function of these cells overlaps in many aspects with previously described effector Treg subsets.</s><s>However, ST2 + Tregs stand out from these populations as they feature a Th2-biased phenotype already under homeostatic conditions.</s><s>Additionally, these cells employ a mechanism based on IL-10 and increased TGFβ production and activation to mediate their enhanced suppressive function.</s><s>Due to their specific capabilities, ST2 + Tregs may be suitable for targeted immunomodulatory therapies, e.g. to alleviate allergies or autoimmunity.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>First, we</head><label></label><figDesc><div><p><s>wanted to assess whether IL-33 signaling via the ST2 receptor is necessary for the development and maintenance of ST2 + Tregs present under homeostatic conditions.</s><s>Therefore we isolated splenocytes from naive WT mice, and analyzed the frequency of ST2 + and ST2 − Foxp3 + CD4 + T cells(Fig 1A and S1A Fig).</s><s>As reported previously a subpopulation of Tregs expressed the receptor for IL-33.</s><s>Next, we determined the frequency and number of total Tregs in WT, ST2-deficient (Il1rl1 -/-) and Il33 -/mice.</s><s>We found that both the frequency and number of Tregs were largely comparable in the spleen, peripheral lymph nodes (pLN) and lung of these mice (Fig1B).</s><s>Although a significantly elevated frequency of splenic Tregs was detected</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. ST2 + Tregs arise independently of IL-33 signals.</s><s>Phenotype of Tregs in naive WT, Il1rl1 -/and Il33 -/mice: (A) ST2 and Foxp3 expression by splenic CD4 + T cells of one representative naive WT mouse; quadrant numbers indicate the average frequency ± SD in 4 mice.</s><s>(B) Frequencies and total numbers of FoxP3 + Tregs in spleen (Spl), peripheral lymph nodes (pLN) and lung.</s><s>(C) Frequency of ST2 expression in Tregs of spleen and lung.</s><s>(D) Total number of ST2 + Tregs in spleen, pLN and lung.</s><s>Fig 2A, 2C and 2D: Data are representative of at least 2 independent experiments.</s><s>Fig 2B: Pooled data from 2 independent experiments, each with 4 mice per genotype.</s><s>Bar graphs show the mean ± SD of at least 4 individual mice.</s><s>Significance was tested using unpaired Student's t test.</s><s>Asterisks indicate significance; all others non-significant.</s><s>* p 0.05; ** p 0.01; *** p 0.001.</s><s>doi:10.1371/journal.pone.0161507.g001</s></p></div></figDesc><graphic coords="4,180.00,397.25,396.00,219.46" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>4 +</head><label>4</label><figDesc><div><p><s>Tregs was clearly increased in the ST2 + compartment, especially within lymphoid tissues (Fig 2D).</s><s>Moreover, we analyzed the expression of transcription factors in the ST2 + and ST2 − Treg subsets.</s><s>Both the Treg-key regulator Foxp3 as well as the Th2-associated transcription factor GATA-3 were elevated in ST2 + Tregs (Fig 2E and S3A Fig).</s><s>In contrast, expression of T-bet, which can be induced in Tregs upon Th1-differentiating antigen encounter [13], was not altered (S3B Fig).</s><s>Although specific to ST2 + Tregs, we found the expression of all of the aforementioned molecules to be independent of IL-33 (S3C and S3D Fig).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. ST2 + Tregs preferentially home outside of secondary lymphoid organs and exhibit a highly activated phenotype.</s><s>Flow cytometric analysis of the phenotype and frequency of WT ST2 + and ST2 − Foxp3 + Tregs in spleen, pLN, blood, lung, lamina propria of the small intestine (siLP) and colon (coLP): (A) Frequency of ST2 + Tregs (left) and MFI of the ST2 staining on the ST2 + Treg fraction (right).</s><s>(B) MFI of chemokine receptor and α4β7 staining on ST2 + and ST2 − Tregs.</s><s>(C) KLRG1 and CD103 expression in ST2 + (top) and ST2 − (bottom) Tregs from spleen; quantified frequencies from indicated organs (right).</s><s>(D) Frequency of CD44 hi , CD62L lo and CTLA-4 + T cells within ST2 + and ST2 − Treg populations.</s><s>(E) MFI of the Foxp3 staining (left) and geometric mean index of GATA-3 (right) in ST2 + and ST2 − Tregs.</s><s>(F) Quantification of mRNA expression of the indicated genes from FACS-sorted ST2 + and ST2 − CD25 + Tregs from spleen and pLN ex vivo.</s><s>mRNA expression normalized to Hprt endogenous control.</s><s>(G) Frequency of ST2 + and ST2 − Tregs with IL-10 production capability as detected by GFP expression from B6. Foxp3 hCD2 xIl10 gfp reporter mice.</s><s>Fig 2A: Data are representative of at least 2 independent experiments.</s><s>Bar graphs show the mean ± SD of at least 5 biological replicates.</s><s>Fig 2B: pooled data from 2 independent experiments with 3-5 biological replicates each.</s><s>Bar graphs show the mean ± SD.</s><s>Fig 2C-2E and 2G: Data are representative of at least 2 independent experiments.</s><s>Scatter plots depict one mouse as individual dot with mean ± SD.</s><s>Fig 2F: pooled data from 2 independent experiments.</s><s>Significance was tested using unpaired Student's t test.</s><s>* p 0.05; ** p 0.01; *** p 0.001; non-significant (ns) p &gt; 0.05.</s><s>doi:10.1371/journal.pone.0161507.g002</s></p></div></figDesc><graphic coords="6,80.62,76.20,495.33,311.02" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. ST2 + Tregs suppress CD4 + T cell proliferation more effectively than ST2 − Tregs in vitro.</s><s>(A) Proliferation profiles of CellTrace-labelled WT CD25 -CD62L hi CD4 + responder T cells (Tresp) co-cultured with WT ST2 + (black) and ST2 − (grey) CD25 + Tregs during an in vitro suppression assay at day 4 of culture.</s><s>T cells were stimulated by APCs and anti-CD3 antibody with (right column) or without (left column) the addition of recombinant IL-33.</s><s>Treg:Tresp ratios are indicated (left).</s><s>Percentage of divided cells and the division index (number in brackets) are shown in each histogram in the respective color.</s><s>(B) Proliferation profile of Tresp cultured under the same conditions as in 3A but without Tregs, either with (grey) or without (black) the addition of anti-CD3 antibody.</s><s>(C) MFI of the ST2 staining on all Tregs recovered from the cultures described in 3A.</s><s>Data are representative of 2-3 independent experiments.</s><s>doi:10.1371/journal.pone.0161507.g003</s></p></div></figDesc><graphic coords="7,180.00,79.48,396.00,431.83" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>ST2+</head><label></label><figDesc><div><p><s>Tregs express TGFβ and the Th2 cytokines IL-5, IL-13 and IL-10 Although IL-33 did not influence the suppressive capacity of ST2 + Tregs in vitro, it still increased the amount of ST2 expressed on their cell surface.</s><s>To assess whether other functions are affected by the capacity of ST2 + Tregs to sense IL-33, we stimulated ST2 + and ST2 − Tregs in vitro in the presence or absence of this cytokine.</s><s>We observed that the number of living cells was highest when ST2 + Tregs were cultured in the presence of IL-33 (Fig 4A).</s><s>Thus, IL-33 affects either their proliferation or survival.</s><s>Moreover, ST2 + Tregs produced more TGFβ, IL-5, IL-13 and IL-10 at the mRNA and protein level than their ST2 − counterparts, and the production of the Th2-associated cytokines IL-5 and IL-13 was vastly increased by IL-33 (Fig 4B and 4C, S4 Fig).</s><s>GATA-3 expression was also significantly higher in ST2 + than ST2 − Tregs but unaffected by IL-33 signaling (Fig 4D).</s><s>In contrast, IFNγ secretion was significantly lower by ST2 + than ST2 − Tregs.</s><s>Almost no IL-4 was detectable in the supernatants of stimulated ST2 + and ST2 − Tregs with only minor differences between the groups.</s><s>Hence, we conclude that IL-33 positively influences the expansion of ST2 + Tregs and promotes the production of the Th2 cytokines IL-5 and IL-13.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. ST2 + Tregs express Th2 cytokines and suppress CD4 + T cell proliferation via IL-10 and TGFβ.</s><s>(A-D) ST2 + and ST2 − Tregs from spleen and lymph nodes of WT mice activated in vitro by plate-bound anti-CD3/anti-CD28 antibodies in the presence of IL-2 with or without recombinant IL-33 for 60-70 hours: (A) Fold change in the number of viable Tregs upon IL-33 treatment.</s><s>(B) Tgfb1 mRNA expression normalized to Hprt endogenous control.</s><s>(C) Cytokine concentration in the supernatants as determined by cytometric bead array.</s><s>(D) Geometric mean index of GATA-3 in stable ST2 + and ST2 − Tregs at the end of culture.</s><s>(E) In vitro suppression assay with ST2 + and ST2 − Tregs as described in Fig 3 (Treg:Tresp ratio 1:5) with addition of blocking anti-IL-10R antibody or TGFβRI inhibitor.</s><s>The relative division index indicates the fold increase in division of Tresp upon treatment.</s><s>Division index of untreated Tresp was set to 1 in each group.</s><s>(F) Quantification of mRNA expression of the indicated genes from sorted ST2 + and ST2 − CD25 + Tregs ex vivo.</s><s>mRNA expression normalized to Hprt endogenous control.</s><s>Fig 4A-4C, 4E and 4F, data pooled from 2-3 independent experiments each performed with 2 replicates per condition.</s><s>Fig 4D is representative of 2 independent experiments with at least 2 replicates per condition each.</s><s>Bar graphs show the mean ± SD.</s><s>Significance was tested using unpaired Student's t test.</s><s>* p 0.05; ** p 0.01; *** p 0.001; non-significant (ns) p &gt; 0.05.</s><s>doi:10.1371/journal.pone.0161507.g004</s></p></div></figDesc><graphic coords="8,81.98,390.33,494.14,193.89" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>(</head><label></label><figDesc><div><p><s>black line) and ST2 − Tregs (grey) from naive WT mice.</s><s>T-bet expression by the endogenous T-bet hi CD4 + population is depicted as dotted line.</s><s>(C) Frequency of KLRG1, CD103, CTLA-4 and CD44 expressing ST2 + and ST2 − Tregs in the spleen, pLN and lung of WT and Il33 -/mice ex vivo.</s><s>(D) MFI of GATA-3 in ST2 + Tregs of WT and Il33 -/mice ex vivo.</s><s>Data are representative of at least 2 independent experiments, each performed with 4 replicates per condition.</s><s>S3C Fig: Bar graphs show the mean ± SD.</s><s>S3B Fig: Scatter plots depict one mouse as individual dot with mean ± SD.</s><s>Significance was tested using unpaired Student's t test.</s><s>Ã p 0.05; non-significant (ns) p &gt; 0.05.</s><s>(TIF) S4 Fig. Cytokine quantity detected in the supernatants of stimulated ST2 + and ST2 − Tregs is reflected at the mRNA level.</s><s>Th2-related cytokine mRNA quantified in 70h in vitro stimulated ST2 + and ST2 − CD25 + Tregs by pate-bound anti-CD3/anti-CD28 antibodies in the presence of IL-2 with or without IL-33.</s><s>mRNA expression normalized to Hprt endogenous control.</s><s>Where possible, fold change in regards to untreated ST2− Tregs is displayed.</s><s>n.d.: non-detectable.</s><s>Data pooled from 2 independent experiments each performed with 2-4 replicates per condition.</s><s>Bar graphs show the mean ± SD.</s><s>Significance was tested using unpaired Student's t test.</s><s>Ã p 0.05; ÃÃ p 0.01; ÃÃÃ p 0.001; non-significant (ns) p &gt; 0.05.</s><s>(TIF) S1 Table.</s><s>Murine qPCR primers.</s><s>(DOCX)</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0161507August 22, 2016  </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We thank S. Ebel for expert technical assistance and animal care, K. Adelmann for experimental support, A.N. McKenzie and P.G.</s><s>Fallon for Il1rl1 -/mice, and C. Baumann and R. Marek for helpful comments on the manuscript.</s><s>Cell sorting was carried out at the Flow Cytometry Core Facility at the German Rheumatism Research Center Berlin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Formal analysis: JS AF.</head><p><s>Funding acquisition: ML.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Investigation: JS AF AD ANH DVV VH.</head><p><s>Methodology: JS AF.</s></p><p><s>Resources: HS SN.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supervision: ML.</head><p><s>Visualization: JS AF.</s></p><p><s>Writing -original draft: JS AF ML.</s></p><p><s>Writing -review &amp; editing: JS AF ML.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head><p><s>Conceptualization: JS AF ML.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Development and maintenance of regulatory T cells. Immunity</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ohkura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kitagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sakaguchi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2013.03.002</idno>
		<idno type="PMID">23521883</idno>
		<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="414" to="423" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Rudensky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Regulatory</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-065X.2011.01018.x</idno>
		<idno type="PMID">21488902</idno>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">241</biblScope>
			<biblScope unit="page" from="260" to="268" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Regulatory T cells in nonlymphoid tissues</title>
		<author>
			<persName><forename type="first">D</forename><surname>Burzyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Benoist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mathis</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni.2683</idno>
		<idno type="PMID">24048122</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1007" to="1013" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Phenotypical and functional specialization of FOXP3+ regulatory T cells</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Koch</surname></persName>
		</author>
		<idno type="DOI">10.1038/nri2916</idno>
		<idno type="PMID">21267013</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Mechanisms of foxp3+ T regulatory cell-mediated suppression</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shevach</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2009.04.010</idno>
		<idno type="PMID">19464986</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="636" to="645" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">How many mechanisms do regulatory T cells need?</title>
		<author>
			<persName><forename type="first">D</forename><surname>Vignali</surname></persName>
		</author>
		<idno type="DOI">10.1002/eji.200738114</idno>
		<idno type="PMID">18395857</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="908" to="911" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Homeostatic control of regulatory T cell diversity</title>
		<author>
			<persName><forename type="first">A</forename><surname>Liston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Gray</surname></persName>
		</author>
		<idno type="DOI">10.1038/nri3605</idno>
		<idno type="PMID">24481337</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="154" to="165" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25-regulatory T cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lehmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huehn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De La Rosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Maszyna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kretschmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Krenn</surname></persName>
		</author>
		<idno type="PMID">12242333</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="13031" to="13036" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Developmental stage, phenotype, and migration distinguish naive-and effector/memory-like CD4+ regulatory T cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Huehn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Siegmund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Lehmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Siewert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Haubold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Feuerer</surname></persName>
		</author>
		<idno type="PMID">14757740</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">199</biblScope>
			<biblScope unit="page" from="303" to="313" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Sather</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Treuting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Perdue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miazgowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Fontenot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Rudensky</surname></persName>
		</author>
		<idno type="PMID">17548521</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page" from="1335" to="1347" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Characterization of mouse CD4 T cell subsets defined by expression of KLRG1</title>
		<author>
			<persName><forename type="first">N</forename><surname>Beyersdorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Tietze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hanke</surname></persName>
		</author>
		<idno type="PMID">18034419</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="3445" to="3454" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells</title>
		<author>
			<persName><forename type="first">G</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Podack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Malek</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.1103768</idno>
		<idno type="PMID">22786769</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="page" from="1780" to="1791" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Koch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tucker-Heard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Perdue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Killebrew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Urdahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Campbell</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni.1731</idno>
		<idno type="PMID">19412181</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="595" to="602" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<author>
			<persName><forename type="first">A</forename><surname>Chaudhry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rudra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Treuting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Samstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kas</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1172702</idno>
		<idno type="PMID">19797626</idno>
	</analytic>
	<monogr>
		<title level="m">CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner</title>
				<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">326</biblScope>
			<biblScope unit="page" from="986" to="991" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Foxp3+ follicular regulatory T cells control the germinal center response</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Linterman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pierson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kallies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kawamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Rayner</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm.2425</idno>
		<idno type="PMID">21785433</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="975" to="982" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">I</forename><surname>Nurieva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rawal</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm.2426</idno>
		<idno type="PMID">21785430</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="983" to="988" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Wohlfert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Grainger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bouladoux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Konkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Oldenhove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Ribeiro</surname></persName>
		</author>
		<idno type="DOI">10.1172/JCI57456</idno>
		<idno type="PMID">21965331</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="4503" to="4515" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Wan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2011.08.012</idno>
		<idno type="PMID">21924928</idno>
		<imprint>
			<date type="published" when="2011">2011</date>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="337" to="348" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Leonard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Zhao</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0906988106</idno>
		<idno type="PMID">19666510</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="13463" to="13468" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The alarmin IL-33 promotes regulatory T-cell function in the intestine</title>
		<author>
			<persName><forename type="first">C</forename><surname>Schiering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Krausgruber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chomka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Frohlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Adelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Wohlfert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T celldependent promotion of cardiac allograft survival</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Turnquist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Rosborough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Castellaneta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Isse</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.1100519</idno>
		<idno type="PMID">21949025</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="4598" to="4610" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Matta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Mathews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Rosborough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Blazar</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.1400481</idno>
		<idno type="PMID">25217167</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">193</biblScope>
			<biblScope unit="page" from="4010" to="4020" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3(+) regulatory T-cell responses in mice</title>
		<author>
			<persName><forename type="first">L</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Xiong</surname></persName>
		</author>
		<idno type="DOI">10.2119/molmed.2011.00428</idno>
		<idno type="PMID">22426954</idno>
	</analytic>
	<monogr>
		<title level="j">Mol Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="753" to="761" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vasanthakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Moro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Xin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gloury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kawamoto</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni.3085</idno>
		<idno type="PMID">25599561</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="276" to="285" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">IL-33 is a crucial amplifier of innate rather than acquired immunity</title>
		<author>
			<persName><forename type="first">K</forename><surname>Oboki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kajiwara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ishii</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1003059107</idno>
		<idno type="PMID">20937871</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="18581" to="18586" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Townsend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Fallon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Jolin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Mckenzie</surname></persName>
		</author>
		<idno type="PMID">10727469</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="page" from="1069" to="1076" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Kendal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Regateiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Cobbold</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.20110767</idno>
		<idno type="PMID">21875958</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">208</biblScope>
			<biblScope unit="page" from="2043" to="2053" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kamanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Sutterwala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lara-Tejero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Galan</surname></persName>
		</author>
		<idno type="PMID">17137799</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="941" to="952" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Migration rules: functional properties of naive and effector/memorylike regulatory T cell subsets</title>
		<author>
			<persName><forename type="first">J</forename><surname>Huehn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Siegmund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hamann</surname></persName>
		</author>
		<idno type="PMID">15981477</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Top Microbiol Immunol</title>
		<imprint>
			<biblScope unit="volume">293</biblScope>
			<biblScope unit="page" from="89" to="114" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model</title>
		<author>
			<persName><forename type="first">H</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Miyazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yoshie</forename><forename type="middle">O</forename></persName>
		</author>
		<idno type="PMID">17989707</idno>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="171" to="182" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Trafficking of regulatory T cells in the intestinal immune system</title>
		<author>
			<persName><forename type="first">O</forename><surname>Pabst</surname></persName>
		</author>
		<idno type="DOI">10.1093/intimm/dxs113</idno>
		<idno type="PMID">23257631</idno>
	</analytic>
	<monogr>
		<title level="j">Int Immunol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="139" to="143" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs</title>
		<author>
			<persName><forename type="first">R</forename><surname>Forster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schubel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Breitfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kremmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Renner-Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wolf</forename><forename type="middle">E</forename></persName>
		</author>
		<idno type="PMID">10520991</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="23" to="33" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Meingassner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lipp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rot</surname></persName>
		</author>
		<idno type="PMID">17371928</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page" from="735" to="745" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Soong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Konig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Chopra</surname></persName>
		</author>
		<idno type="DOI">10.1186/1745-6150-4-40</idno>
		<idno type="PMID">19852824</idno>
	</analytic>
	<monogr>
		<title level="j">Biol Direct</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">40</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential</title>
		<author>
			<persName><forename type="first">S</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Yopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Mao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chen</surname></persName>
		</author>
		<idno type="PMID">14678036</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Transplant</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="65" to="78" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Thornton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shevach</surname></persName>
		</author>
		<idno type="PMID">10605010</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="183" to="190" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kuniyasu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Toda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sakaguchi</surname></persName>
		</author>
		<idno type="PMID">10917889</idno>
	</analytic>
	<monogr>
		<title level="j">Int Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1145" to="1155" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">CTLA-4 control over Foxp3+ regulatory T cell function</title>
		<author>
			<persName><forename type="first">K</forename><surname>Wing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Onishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Prieto-Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miyara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Fehervari</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1160062</idno>
		<idno type="PMID">18845758</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">322</biblScope>
			<biblScope unit="page" from="271" to="275" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Gorentla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">P</forename><surname>Zhong</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.1102448</idno>
		<idno type="PMID">22231701</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page" from="1698" to="1707" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells</title>
		<author>
			<persName><forename type="first">E</forename><surname>Cretney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Xin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Minnich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Masson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miasari</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni.2006</idno>
		<idno type="PMID">21378976</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol. 2011</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="304" to="311" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<title level="m" type="main">Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Rubtsov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Y</forename><surname>Chi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fontenot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Castelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ye</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2008.02.017</idno>
		<idno type="PMID">18387831</idno>
		<imprint>
			<date type="published" when="2008">2008</date>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="546" to="558" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<monogr>
		<title level="m" type="main">Regulatory T cells: how do they suppress immune responses? Int Immunol</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sakaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Onishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Prieto-Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamaguchi</surname></persName>
		</author>
		<idno type="DOI">10.1093/intimm/dxp095</idno>
		<idno type="PMID">19737784</idno>
		<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1105" to="1111" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">TGF-beta-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling</title>
		<author>
			<persName><forename type="first">T</forename><surname>Oida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Weiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kitani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Strober</surname></persName>
		</author>
		<idno type="PMID">16887994</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="2331" to="2339" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Integrin alphavbeta8-Mediated TGF-beta Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Worthington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Smedley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bauche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Marie</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2015.04.012</idno>
		<idno type="PMID">25979421</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="903" to="915" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">A special population of regulatory T cells potentiates muscle repair</title>
		<author>
			<persName><forename type="first">D</forename><surname>Burzyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kuswanto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kolodin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Shadrach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cerletti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2013.10.054</idno>
		<idno type="PMID">24315098</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="1282" to="1295" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">IL-33 Reverses an Obesity-Induced Deficit in Visceral Adipose Tissue ST2+ T Regulatory Cells and Ameliorates Adipose Tissue Inflammation and Insulin Resistance</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Denroche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Verchere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Levings</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.1500020</idno>
		<idno type="PMID">25870243</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">194</biblScope>
			<biblScope unit="page" from="4777" to="4783" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title level="m" type="main">The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel &apos;alarmin&apos;? PLoS One</title>
		<author>
			<persName><forename type="first">C</forename><surname>Moussion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ortega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Girard</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0003331</idno>
		<idno type="PMID">18836528</idno>
		<imprint>
			<date type="published" when="2008">2008</date>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e3331</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain</title>
		<author>
			<persName><forename type="first">M</forename><surname>Pichery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mirey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mercier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lefrancais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dujardin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ortega</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.1101977</idno>
		<idno type="PMID">22371395</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page" from="3488" to="3495" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Cipolletta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Feuerer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kamei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Shoelson</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature11132</idno>
		<idno type="PMID">22722857</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">486</biblScope>
			<biblScope unit="page" from="549" to="553" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Antigen-and cytokinedriven accumulation of regulatory T cells in visceral adipose tissue of lean mice</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kolodin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Van Panhuys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Magnuson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cipolletta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Miller</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cmet.2015.03.005</idno>
		<idno type="PMID">25863247</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="543" to="557" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Evidence for multiple promoters of the human IL-5 receptor alpha subunit gene: a novel 6-base pair element determines cellspecific promoter function</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kuvelkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Cheewatrakoolpong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Egan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Billah</surname></persName>
		</author>
		<idno type="PMID">9548481</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="5412" to="5421" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ray</surname></persName>
		</author>
		<idno type="PMID">9780145</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="3817" to="3821" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Max-Audit I, Interleukin-13 gene expression is regulated by GATA-3 in T cells: role of a critical association of a GATA and two GATG motifs</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lavenu-Bombled</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Trainor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Makeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Romeo</surname></persName>
		</author>
		<idno type="PMID">11893731</idno>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="18313" to="18321" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Tiemessen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Jagger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Van Herwijnen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>John</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Taams</surname></persName>
		</author>
		<idno type="PMID">18042719</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="19446" to="19451" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines</title>
		<author>
			<persName><forename type="first">J</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Owyang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Oldham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Mcclanahan</surname></persName>
		</author>
		<idno type="PMID">16286016</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="479" to="490" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">A Distinct Function of Regulatory T Cells in Tissue Protection</title>
		<author>
			<persName><forename type="first">N</forename><surname>Arpaia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Moltedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Arvey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hemmers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yuan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2015.08.021</idno>
		<idno type="PMID">26317471</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="1078" to="1089" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells</title>
		<author>
			<persName><forename type="first">W</forename><surname>Kuswanto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Burzyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Panduro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Wagers</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2016.01.009</idno>
		<idno type="PMID">26872699</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="355" to="367" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta</title>
		<author>
			<persName><forename type="first">K</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kitani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Strober</surname></persName>
		</author>
		<idno type="PMID">11535631</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">194</biblScope>
			<biblScope unit="page" from="629" to="644" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35-and IL-10-dependent manner</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Collison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Pillai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Chaturvedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Vignali</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.0803646</idno>
		<idno type="PMID">19414764</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="page" from="6121" to="6128" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Piccirillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Letterio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Thornton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Mchugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mizuhara</surname></persName>
		</author>
		<idno type="PMID">12119348</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">196</biblScope>
			<biblScope unit="page" from="237" to="246" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Thornton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Shevach</surname></persName>
		</author>
		<idno type="PMID">9670041</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page" from="287" to="296" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state</title>
		<author>
			<persName><forename type="first">T</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kuniyasu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Toda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sakaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Iwata</surname></persName>
		</author>
		<idno type="PMID">9885918</idno>
	</analytic>
	<monogr>
		<title level="j">Int Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1969" to="1980" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
